Taconic Biosciences is fully licensed to generate and distribute genetically engineered mouse and rat models.  Learn More


Liver Biopsies in a Mouse Model of NASH

Tuesday, November 19
at 11 a.m. ET

Register Now

White Paper:

Application of CRISPR/Cas-based Technology to the Rapid Generation of Genetically Engineered Mice

Download Now


Use our advanced search tool to find the exact model you need

Read more
  • Genetic Background of Mice Influences Microbiome

    Source: Graphical Abstract. Khan et al., 20191 The microbiome continues to be an important topic in both human health research and in popular culture. The microbiome is cited as a factor in multiple diseases, neurological conditions, and immune responses to foreign pathogens. Specific compositions of... Read more

  • Benefits of Humanized Mice for CAR-T Immunotherapy Studies

    CAR T cell (CAR-T) therapy is a relatively recent immunotherapy with the first drugs approved for human use by the FDA in 2017. This type of immunotherapeutic utilizes T cells extracted from patient blood which are subsequently modified to target cancer cells. The modification enables... Read more

  • Utilizing CRISPR/Cas9 as a genome editing therapeutic in mouse models of human disease

    The application of CRISPR/Cas9 as a mammalian gene editing technology has tremendously matured over the last decade. This has paved the way for the development of CRISPR/Cas9 as therapeutic tool to treat human genetic disease, while making it easier to create the genetically modified animal... Read more

  • SIOP and Russell & Burch's 3Rs

    R.L. Burch and W.M.S. Russell2 W.M.S. Russell (1925-2006) and R.L. Burch (1926-1996) originated the concepts of replacement, reduction, and refinement, which they published in their 1959 book, The Principles of Humane Experimental Technique (Principles)1. The Principles was presented not as the final word of this... Read more

  • Alzheimer's Disease: Steps towards more translational research models

    Alzheimer's Disease International reports there are 50 million people worldwide living with Alzheimer's Disease (AD), but there remain few approved treatments and no cure. The amount spent to care for patients with AD is over $1 trillion USD, or 1% of global GDP, and experts... Read more

  • After 40 Years a New TB Drug is Approved

    Source: TB Alliance Nonprofit Wins FDA Approval for Tuberculosis Drug At the end of the summer, the TB Alliance announced the approval of a new drug to treat some of the most drug-resistant forms of tuberculosis (TB). This is the first time the US Food... Read more

  • RNA Therapeutics: siRNA

    RNA-based therapeutics are a relatively new class of drugs based on RNA sequences. There are three main classes of RNA therapeutics: small interfering RNA (siRNA), RNA aptamers, and ribozymes. siRNA Therapeutics and Gene Expression Last year, the first siRNA-based therapeutic was approved by the FDA.... Read more

  • New gene therapy for the treatment of Alzheimer's Disease

    It is estimated that 5.8 million Americans are currently living with Alzheimer's Disease (AD). AD is a progressive, lifelong condition for which there is currently no cure. Treatment consists of managing the symptoms associated with the disease and include medicines that aim to maintain mental... Read more